Downregulation of Dock1 and Elmo1 suppresses the migration and invasion of triple‑negative breast cancer epithelial cells through the RhoA/Rac1 pathway

Liang,Yueyang; Wang,Shushu; Zhang,Yi

doi:10.3892/ol.2018.9077

Downregulation of Dock1 and Elmo1 suppresses the migration and invasion of triple‑negative breast cancer epithelial cells through the RhoA/Rac1 pathway

Authors:
- Yueyang Liang
- Shushu Wang
- Yi Zhang
View Affiliations

Affiliations: Breast Disease Center, Southwest Hospital, Army Medical University, Chongqing 400038, P.R. China
Published online on: July 4, 2018 https://doi.org/10.3892/ol.2018.9077
Pages: 3481-3488
Copyright: © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dedicator of cytokinesis 1 (Dock1), a guanine nucleotide exchange factor, has been proven to facilitate cell survival, motility and proliferation via the activation of Ras‑related C3 botulinum toxin substrate 1 (Rac1). Engulfment and cell motility 1 (Elmo1) serves as a mammalian homolog of Ced‑12, which has been evolutionarily conserved from worm to human. The present study aimed to investigate the roles and mechanisms of Dock1 and Elmo1 in the migration and invasion of triple‑negative breast cancer (TNBC) epithelial cells. Cell Counting kit‑8, cell migration and cell invasion assays were performed to assess cell viability, migration and invasion, respectively. A plate clone formation assay was performed to determine cell proliferation. Western blot analysis and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) assays were used to evaluate mRNA and protein expression. The results revealed that the downregulation of Dock1 and Elmo1 inhibited cell viability, suppressed migration and invasion, and reduced Rac1 activity in MDA‑MB‑231 cells. Furthermore, downregulation of Dock1 and Elmo1 also attenuated the expression of migration‑associated proteins and affected the Ras homolog gene family, member A (RhoA)/Rac1 pathway in MDA‑MB‑231 cells. In conclusion, the results of the present study suggested that the downregulation of Dock1 and Elmo1 suppresses the migration and invasion of TNBC epithelial cells through the RhoA/Rac1 pathway.

View Figures

View References

1	DeSantis C, Ma J, Bryan L and Jemal A: Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014. View Article : Google Scholar : PubMed/NCBI
2	Donepudi MS, Kondapalli K, Amos SJ and Venkanteshan P: Breast cancer statistics and markers. J Cancer Res Ther. 10:506–511. 2014.PubMed/NCBI
3	Weigelt B, Eberle C, Cowell CF, Ng CK and Reis-Filho JS: Metaplastic breast carcinoma: More than a special type. Nat Rev Cancer. 14:147–148. 2014. View Article : Google Scholar : PubMed/NCBI
4	Denkert C, Liedtke C, Tutt A and von Minckwitz G: Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet. 389:2430–2442. 2017. View Article : Google Scholar : PubMed/NCBI
5	Bianchini G, Balko JM, Mayer IA, Sanders ME and Gianni L: Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 13:674–690. 2016. View Article : Google Scholar : PubMed/NCBI
6	Wojciak-Stothard B and Ridley AJ: Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol. 39:187–199. 2002. View Article : Google Scholar : PubMed/NCBI
7	Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y and Yoshida K: Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res. 10:4799–4805. 2004. View Article : Google Scholar : PubMed/NCBI
8	Rihet S, Vielh P, Camonis J, Goud B, Chevillard S and de Gunzburg J: Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors. J Cancer Res Clin Oncol. 127:733–738. 2001.PubMed/NCBI
9	Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y and Fan D: Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun. 315:686–691. 2004. View Article : Google Scholar : PubMed/NCBI
10	Simpson KJ, Dugan AS and Mercurio AM: Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res. 64:8694–8701. 2004. View Article : Google Scholar : PubMed/NCBI
11	Cote JF and Vuori K: GEF what? Dock180 and related proteins help Rac to polarize cells in new ways. Trends Cell Biol. 17:383–393. 2007. View Article : Google Scholar : PubMed/NCBI
12	Feng H, Hu B, Liu KW, Li Y, Lu X, Cheng T, Yiin JJ, Lu S, Keezer S, Fenton T, et al: Activation of Rac1 by Src-dependent phosphorylation of Dock180 (Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest. 121:4670–4684. 2011. View Article : Google Scholar : PubMed/NCBI
13	Gumienny TL, Brugnera E, Tosello-Trampont AC, Kinchen JM, Haney LB, Nishiwaki K, Walk SF, Nemergut ME, Macara IG, Francis R, et al: CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell. 107:27–41. 2001. View Article : Google Scholar : PubMed/NCBI
14	Kim K, Lee J, Lee SA, Moon H, Park B, Kim D, Joo YE and Park D: Intermolecular steric inhibition of Ephexin4 is relieved by Elmo1. Sci Rep. 7:44042017. View Article : Google Scholar : PubMed/NCBI
15	Hamoud N, Tran V, Croteau LP, Kania A and Cote JF: G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates. Proc Natl Acad Sci USA. 111:3745–3750. 2014. View Article : Google Scholar : PubMed/NCBI
16	Hochreiter-Hufford AE, Lee CS, Kinchen JM, Sokolowski JD, Arandjelovic S, Call JA, Klibanov AL, Yan Z, Mandell JW and Ravichandran KS: Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature. 497:263–267. 2013. View Article : Google Scholar : PubMed/NCBI
17	Katoh H and Negishi M: RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. Nature. 424:461–464. 2003. View Article : Google Scholar : PubMed/NCBI
18	Park D and Ravichandran KS: Emerging roles of brain-specific angiogenesis inhibitor 1. Adv Exp Med Biol. 706:167–178. 2010. View Article : Google Scholar : PubMed/NCBI
19	Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW and Ravichandran KS: BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature. 450:430–434. 2007. View Article : Google Scholar : PubMed/NCBI
20	Xiao Y, Peng Y, Wan J, Tang G, Chen Y, Tang J, Ye WC, Ip NY and Shi L: The atypical guanine nucleotide exchange factor Dock4 regulates neurite differentiation through modulation of Rac1 GTPase and actin dynamics. J Biol Chem. 288:20034–20045. 2013. View Article : Google Scholar : PubMed/NCBI
21	Laurin M, Huber J, Pelletier A, Houalla T, Park M, Fukui Y, Haibe-Kains B, Muller WJ and Côté JF: Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis. Proc Natl Acad Sci USA. 110:7434–7439. 2013. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R and Cheng SY: ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res. 67:7203–7211. 2007. View Article : Google Scholar : PubMed/NCBI
24	Grimsley CM, Kinchen JM, Tosello-Trampont AC, Brugnera E, Haney LB, Lu M, Chen Q, Klingele D, Hengartner MO and Ravichandran KS: Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J Biol Chem. 279:6087–6097. 2004. View Article : Google Scholar : PubMed/NCBI
25	Wang J, Dai JM, Che YL, Gao YM, Peng HJ, Liu B, Wang H and Linghu H: Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer. Int J Gynecol Cancer. 24:844–850. 2014. View Article : Google Scholar : PubMed/NCBI
26	Balassa T, Berta G, Jakab L, Bohonyi N and Szekeres-Bartho J: The effect of the Progesterone-Induced Blocking Factor (PIBF) on E-cadherin expression, cell motility and invasion of primary tumour cell lines. J Reprod Immunol. 125:8–15. 2018. View Article : Google Scholar : PubMed/NCBI
27	Sanders MA, Ampasala D and Basson MD: DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV. J Biol Chem. 284:27–35. 2009. View Article : Google Scholar : PubMed/NCBI
28	Shi L, Zhang B, Sun X, Zhang X, Lv S, Li H, Wang X, Zhao C, Zhang H, Xie X, et al: CC chemokine ligand 18 (CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway. Mol Carcinog. 55:2051–2062. 2016. View Article : Google Scholar : PubMed/NCBI
29	Tajiri H, Uruno T, Shirai T, Takaya D, Matsunaga S, Setoyama D, Watanabe M, Kukimoto-Niino M, Oisaki K, Ushijima M, et al: Targeting ras-driven cancer cell survival and invasion through selective inhibition of DOCK1. Cell Rep. 19:969–980. 2017. View Article : Google Scholar : PubMed/NCBI
30	Gu S, Papadopoulou N, Nasir O, Föller M, Alevizopoulos K, Lang F and Stournaras C: Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling. Mol Med. 17:48–58. 2011. View Article : Google Scholar : PubMed/NCBI
31	Huang C, Rajfur Z, Yousefi N, Chen Z, Jacobson K and Ginsberg MH: Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol. 11:624–630. 2009. View Article : Google Scholar : PubMed/NCBI
32	Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2:249–256. 2000. View Article : Google Scholar : PubMed/NCBI
33	Dreissigacker U, Mueller MS, Unger M, Siegert P, Genze F, Gierschik P and Giehl K: Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. Cell Signal. 18:1156–1168. 2006. View Article : Google Scholar : PubMed/NCBI
34	Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T and Evers BM: mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 71:3246–3256. 2011. View Article : Google Scholar : PubMed/NCBI
35	Parri M and Chiarugi P: Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal. 8:232010. View Article : Google Scholar : PubMed/NCBI
36	Zhao Y, Li J, Xing Y, Wang J, Lu C, Xin X and Geng M: N-acetylglucosaminyltransferase V mediates cell migration and invasion of mouse mammary tumor cells 4TO7 via RhoA and Rac1 signaling pathway. Mol Cell Biochem. 309:199–208. 2008. View Article : Google Scholar : PubMed/NCBI
37	Baugher PJ, Krishnamoorthy L, Price JE and Dharmawardhane SF: Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Breast Cancer Res. 7:R965–R974. 2005. View Article : Google Scholar : PubMed/NCBI
38	Bourguignon LY, Zhu H, Shao L and Chen YW: CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem. 275:1829–1838. 2000. View Article : Google Scholar : PubMed/NCBI
39	Burbelo P, Wellstein A and Pestell RG: Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res Treat. 84:43–48. 2004. View Article : Google Scholar : PubMed/NCBI